Abstract
Due to the rise of the emerging disease COVID-19 and the countless challenges in combating neglected diseases, the 1st Online Congress on Neglected and Emerging Diseases has become even more relevant, and has enabled the addition of knowledge from research and innovation to the clinic of patients for the participants. Moreover, it generated a contribution to the scientific community through the submission of simple and expanded abstracts, in the form of original study, case study, experience report and bibliographic review. This publication has 178 abstracts, 46 of which are simple and 128 expanded, of which 11 are approved by the research ethics committee for carrying out work with human beings. The evaluation of the abstracts was done by peer review and took into account relevance, originality, quality of writing and organization of the text, compliance with the rules and fitting into the scope of the event (neglected and emerging diseases) within the thematic areas: Pharmaceutical Assistance / Hospital; Drug Synthesis and Planning; Pharmaceutical Technology / Biotechnology; Epidemiology; Public health; Parasitology / Microbiology and Diagnostic Methods.
